SB 225002
Tocris Bioscience, part of Bio-Techne | Catalog # 2725
Potent and selective CXCR2 antagonist
Key Product Details
Description
Potent and selective CXCR2 antagonist
Product Description
SB 225002 is a potent and selective CXCR2 chemokine receptor antagonist (IC50 = 22 nM) that displays > 150-fold selectivity over CXCR1 receptors. Causes inhibition of IL-8 and GROα-mediated calcium mobilization in HL60 cells (IC50 values are 8 and 10 nM respectively). Prevents IL-8-induced neutrophil chemotaxis in vitro and sequestration in vivo. Inhibits HIV replication in lymphocytes and macrophages.Licensing Information
Sold for research purposes under agreement from GlaxoSmithKlineProduct Specifications
Molecular Weight
352.14
Formula
C13H10BrN3O4
Storage
Store at RT
Purity
≥98% (HPLC)
Chemical Name
N-(2-Bromophenyl)-N'-(2-hydroxy-4-nitrophenyl)urea
CAS Number
182498-32-4
PubChem ID
3854666
InChI Key
MQBZVUNNWUIPMK-UHFFFAOYSA-N
SMILES
OC1=CC(=CC=C1NC(=O)NC1=CC=CC=C1Br)[N+]([O-])=O
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 35.21 | 100 | |
| Ethanol | 17.61 | 50 |
Preparing Stock Solutions
for SB 225002
The following data is based on the product molecular weight 352.14
Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 2.84 mL | 14.20 mL | 28.40 mL |
| 5 mM | 0.57 mL | 2.84 mL | 5.68 mL |
| 10 mM | 0.28 mL | 1.42 mL | 2.84 mL |
| 50 mM | 0.06 mL | 0.28 mL | 0.57 mL |
Calculators
Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Background References
References are publications that support the biological activity of the product.
- Lane Interleukin-8 stimulates human immunodeficiency virus type 1 replication and is a potential new target for antiretroviral therapy. J.Virol. 2001 PMID: 11483765
- Catusse Characterization of the molecular interactions of interleukin-8 (CXCL8), growth related oncogen a (CXCL1) and a non-peptide antagonist (SB 225002) with the human CXCR2. Biochem.Pharmacol. 2003 PMID: 12628493
- White Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neutrophil migration. J.Biol.Chem. 1998 PMID: 9553055
Product Specific Notices for SB 225002
For research use only
Loading...
Loading...
Loading...